73 related articles for article (PubMed ID: 3296988)
1. Characterization of a new tumor in NMRI-mice suitable for chemotherapeutic experiments.
Fichtner I; Becker M; Lemm M; Arndt D
Arch Geschwulstforsch; 1987; 57(2):105-14. PubMed ID: 3296988
[TBL] [Abstract][Full Text] [Related]
2. Use of nude mouse xenografts as preclinical drug screens: in vivo activity of established chemotherapeutic agents against melanoma and ovarian carcinoma xenografts.
Taetle R; Rosen F; Abramson I; Venditti J; Howell S
Cancer Treat Rep; 1987 Mar; 71(3):297-304. PubMed ID: 3815395
[TBL] [Abstract][Full Text] [Related]
3. The addition of bryostatin 1 to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy improves response in a CHOP-resistant human diffuse large cell lymphoma xenograft model.
Mohammad RM; Wall NR; Dutcher JA; Al-Katib AM
Clin Cancer Res; 2000 Dec; 6(12):4950-6. PubMed ID: 11156256
[TBL] [Abstract][Full Text] [Related]
4. On the development of models in mice of advanced visceral metastatic disease for anti-cancer drug testing.
Man S; Munoz R; Kerbel RS
Cancer Metastasis Rev; 2007 Dec; 26(3-4):737-47. PubMed ID: 17846863
[TBL] [Abstract][Full Text] [Related]
5. Intralesional topotecan in advanced ovarian cancer: a clinical report, based on a preclinical study.
Nicoletto MO; Padrini R; Palumbo M; Ziade A; Ragazzi RS; Pratesi G; Artioli G; De Cesare M; Zunino F
Oncol Rep; 2002; 9(6):1351-4. PubMed ID: 12375047
[TBL] [Abstract][Full Text] [Related]
6. Effect of five antineoplastic agents on tumor xenografts with different growth rates.
Mattern J; Wayss K; Volm M
J Natl Cancer Inst; 1984 Jun; 72(6):1335-9. PubMed ID: 6587154
[TBL] [Abstract][Full Text] [Related]
7. [Biological parameters of a standardized tumor model for chemotherapeutical and toxicological testing (author's transl)].
Fichtner I; Arnold W; Pehl E
Arch Geschwulstforsch; 1979; 49(5):391-407. PubMed ID: 518249
[TBL] [Abstract][Full Text] [Related]
8. Ovarian reticular cell sarcoma of the mouse (M5076) made resistant to cyclophosphamide.
D'Incalci M; Torti L; Damia G; Erba E; Morasca L; Garattini S
Cancer Res; 1983 Dec; 43(12 Pt 1):5674-80. PubMed ID: 6357429
[TBL] [Abstract][Full Text] [Related]
9. [The kinetics of reticulosarcomatosis development in mice and the effect of chemotherapeutic preparations].
Dronova LM; Belich EI; Erokhin VN
Izv Akad Nauk SSSR Biol; 1976; (1):140-4. PubMed ID: 767388
[No Abstract] [Full Text] [Related]
10. Evaluation of Madison 109 lung carcinoma as a model for screening antitumor drugs.
Rose WC
Cancer Treat Rep; 1981; 65(3-4):299-312. PubMed ID: 7237452
[TBL] [Abstract][Full Text] [Related]
11. Preclinical studies of TW-37, a new nonpeptidic small-molecule inhibitor of Bcl-2, in diffuse large cell lymphoma xenograft model reveal drug action on both Bcl-2 and Mcl-1.
Mohammad RM; Goustin AS; Aboukameel A; Chen B; Banerjee S; Wang G; Nikolovska-Coleska Z; Wang S; Al-Katib A
Clin Cancer Res; 2007 Apr; 13(7):2226-35. PubMed ID: 17404107
[TBL] [Abstract][Full Text] [Related]
12. [A murine model of mammary adenocarcinoma (VI TA2MA-891) with high rate of spontaneous metastases in the lungs].
Gao P; Su Y; Gao Y
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1994 Apr; 16(2):147-52. PubMed ID: 7527302
[TBL] [Abstract][Full Text] [Related]
13. [The potential for enhancing the therapeutic efficacy of antitumor preparations].
Konovalova NP; Volkova LM; Klochko AV
Izv Akad Nauk SSSR Biol; 1989; (3):466-8. PubMed ID: 2760333
[TBL] [Abstract][Full Text] [Related]
14. Fever-range whole body hyperthermia increases the number of perfused tumor blood vessels and therapeutic efficacy of liposomally encapsulated doxorubicin.
Xu Y; Choi J; Hylander B; Sen A; Evans SS; Kraybill WG; Repasky EA
Int J Hyperthermia; 2007 Sep; 23(6):513-27. PubMed ID: 17952765
[TBL] [Abstract][Full Text] [Related]
15. Intralymphatic administration of liposome-encapsulated drugs to mice: possibility for suppression of the growth of tumor metastases in the lymph nodes.
Kaledin VI; Matienko NA; Nikolin VP; Gruntenko YV; Budker VG
J Natl Cancer Inst; 1981 May; 66(5):881-7. PubMed ID: 6939932
[TBL] [Abstract][Full Text] [Related]
16. Intracranial transplantation of human hematopoietic cell lines in nude mice: a preclinical screening model for cytostatic drugs.
Engert A; Kirchner HH; Schaadt M; Diehl V
Anticancer Res; 1987; 7(1):49-53. PubMed ID: 3566183
[TBL] [Abstract][Full Text] [Related]
17. In vivo evaluation of ixabepilone (BMS247550), a novel epothilone B derivative, against pediatric cancer models.
Peterson JK; Tucker C; Favours E; Cheshire PJ; Creech J; Billups CA; Smykla R; Lee FY; Houghton PJ
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6950-8. PubMed ID: 16203787
[TBL] [Abstract][Full Text] [Related]
18. Antitumor, hematostimulative and radioprotective action of water-soluble derivative of propolis (WSDP).
Orsolić N; Basić I
Biomed Pharmacother; 2005 Dec; 59(10):561-70. PubMed ID: 16202559
[TBL] [Abstract][Full Text] [Related]
19. Treatment of human glioma and medulloblastoma tumor lines in athymic mice with diaziquone and diaziquone-based drug combinations.
Schold SC; Friedman HS; Bjornsson TD; Bigner DD
Cancer Res; 1984 Jun; 44(6):2352-7. PubMed ID: 6722774
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy of childhood rhabdomyosarcomas growing as xenografts in immune-deprived mice.
Houghton JA; Houghton PJ; Green AA
Cancer Res; 1982 Feb; 42(2):535-9. PubMed ID: 7034923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
